Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antibody-Drug Conjugates in urothelial, prostate, and renal cell cancers: A review of current and emerging therapies. | Crit Rev Oncol Hematol | 2026 | 41344557 | PubTator, text mining | PubMed |
| New targets of PET imaging for renal cancer. | Semin Nucl Med | 2026 | 41330806 | PubTator, text mining | PubMed |
| CD8+ T-cell Antitumor Immunity via Human iNKT-DC Conjugates. | Cancer Immunol Res | 2026 | 41236542 | PubTator, text mining | PubMed |
| CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models. | Blood Cancer Discov | 2026 | 41144785 | PubTator, text mining | PubMed |
| The Relationship and Mechanism of CD27 with Coronary Atherosclerotic Heart Disease. | Cardiovasc Drugs Ther | 2026 | 40779187 | PubTator, text mining | PubMed |
| Development of an Inflammation-related Gene-based Diagnostic Risk Model and Immune Infiltration Analysis in Bipolar Disorder. | Curr Med Chem | 2026 | 40045861 | PubTator, text mining | PubMed |
| mRNA vaccines transform personalized lung cancer treatment. | Front Immunol | 2025 | 41766818 | PubTator, text mining | PubMed |
| Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis. | Front Immunol | 2025 | 41660625 | PubTator, text mining | PubMed |
| CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signaling. | Res Sq | 2025 | 41510255 | PubTator, text mining | PubMed |
| Single-cell and bulk transcriptomics reveal a CD8+ T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma. | Front Immunol | 2025 | 41459519 | PubTator, text mining | PubMed |
| Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy. | J Immunother Cancer | 2025 | 41453774 | PubTator, text mining | PubMed |
| Lactate metabolism orchestrates immune dysregulation in renal cancer: A multi-omics and causal inference study. | Sci Prog | 2025 | 41406083 | PubTator, text mining | PubMed |
| Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy. | J Transl Med | 2025 | 41366793 | PubTator, text mining | PubMed |
| Genetic Determinants of Chronic Kidney Disease (CKD) in India: A Comprehensive Genomewide Association Study (GWAS) Analysis. | Int J Nephrol | 2025 | 41322097 | PubTator, text mining | PubMed |
| Emerging strategies in CAR-T cell therapy for acute myeloid leukemia: overcoming heterogeneity and improving safety through dual-antigen targeting. | Exp Hematol Oncol | 2025 | 41310898 | PubTator, text mining | PubMed |
| State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. | Int J Mol Sci | 2025 | 41303706 | PubTator, text mining | PubMed |
| Editorial: Achilles heel of CAR T-cell therapy. | Front Immunol | 2025 | 41246303 | PubTator, text mining | PubMed |
| The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy. | J Exp Clin Cancer Res | 2025 | 41233805 | PubTator, text mining | PubMed |
| Metabolic reprogramming through PIM3 inhibition reverses hypoxia-induced CAR-T cell dysfunction in solid tumors. | J Transl Med | 2025 | 41199316 | PubTator, text mining | PubMed |
| Immune checkpoint-based biomarkers for therapeutic response in patients with multiple sclerosis. | Front Immunol | 2025 | 41190076 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=7